Research Paper Volume 12, Issue 8 pp 7112—7128
Identification of immunologic subtype and prognosis of GBM based on TNFSF14 and immune checkpoint gene expression profiling
Figure 8. Survival KM plot by a combined analysis of ICGs and TNFSF14 expression in TCGA. (A) Survival based on high/low IDO-1 expression and TNFSF14 expression. (B) Survival based on high/low CD274 expression and TNFSF14 expression. (C) Survival based on high/low CTLA-4 expression and TNFSF14 expression. (D–F): The best and worst prognosis of the above expression combinations.